Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.36 (
hyaluronidase
)
4,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Urinary acid mucopolysaccharides (AMPS) excretion was investigated in a Japanese case with
Multiple Sulfatase Deficiency
(
MSD
) (
Mucosulfatidosis
). The patient excreted AMPS 4 to 5 times more (as carbazoluronic acid) than controls. The cellulose acetate gel electrophoresis clearly indicated two major AMPS which co-migrated with heparan sulfate and chondroitin sulfate A/C. Enzymic digestion with chondroitinase AC and ABC, and by testicular
hyaluronidase
plus amino sugar analysis also confirmed that our case excreted heparan sulfate and chondroitin sulfate A/C. These findings suggest that there are heterogeneities of urinary AMPS excretion among cases with
MSD
.
...
PMID:Urinary acid mucopolysaccharides in multiple sulfatase deficiency (mucosulfatidosis). 15 21
Extensive chemical analyses of acid mucopolysaccharides (AMPS) were carried out in the urine and tissue (liver and brain) from a Japanese patient and two European patients with
multiple sulfatase deficiency (MSD)
. The Japanese patient with
MSD
contained excessive quantities of heparan sulfate and moderately increased chondroitin sulfate A/C. Urinary excretion of AMPS in
MSD
heterozygotes was increased 2-fold compared to our controls. The urinary pattern of AMPS in the mother of the
MSD
patient showed an increase of 18% heparan sulfate and 36% dermatan sulfate whereas the urinary excretion pattern in the father was increased 21% for heparan sulfate as contrasted to controls (chondroitin sulfate A, 50-52%; chondroitin sulfate C, 38-46%; and heparan sulfate, 3-10%). Seventy-five % of the AMPS and the
MSD
liver was heparan sulfate rather than dermatan sulfate. The degree of accumulation of AMPS in the
MSD
liver was 30-50 times that of the control. Cerebral gray matter from the
MSD
patient contained 30-40 times that of control (relative increase of heparan and dermatan sulfate) whereas only a 5-fold increase was observed in white matter. It seems that a major site of accumulated AMPS appears to be in the gray matter. Carbohydrate analysis of the AMPS obtained from
MSD
urine and tissues was performed by: enzyme digestion with testicular
hyaluronidase
, heparitinase and chondroitinase ABC, cellulose acetate electrophoresis, Dowex-1 column chromatography and amino sugar analysis by amino acid analyzer. These findings indicate that the major accumulated AMPS in
MSD
urine and liver is heparan sulfate and thus, the predominant AMPS metabolic defect in
MSD
is heparan sulfate degradation.
...
PMID:Acid mucopolysaccharide (AMPS) abnormality in multiple sulfatase deficiency: chemical compositions of AMPS in urine and liver. 621 4